|
|
.
See Category: Endocrine, nutritional and metabolic diseases
ICD-10 (CM) Code and Descriptor
|
E21.0 |
Primary hyperparathyroidism
|
E210 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 45.50%
|
20.17%
|
10.86%
|
7.14%
|
4.83%
|
3.30%
|
2.27%
|
1.64%
|
1.20%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E21.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
83970
|
ASSAY OF PARATHORMONE |
28,530
|
41,614
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
20,124
|
20,241
|
|
82306
|
VITAMIN D 25 HYDROXY |
10,785
|
10,786
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
9,953
|
9,980
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
8,366
|
15,840
|
|
82310
|
ASSAY OF CALCIUM |
8,351
|
8,560
|
|
80053
|
COMPREHEN METABOLIC PANEL |
8,154
|
8,156
|
|
J3010
|
FENTANYL CITRATE INJECTION |
7,400
|
13,654
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
7,054
|
254,915
|
|
60500
|
EXPLORE PARATHYROID GLANDS |
7,049
|
7,057
|
|
J2405
|
ONDANSETRON HCL INJECTION |
6,938
|
30,617
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
5,863
|
44,604
|
|
84443
|
ASSAY THYROID STIM HORMONE |
5,752
|
5,756
|
|
80048
|
METABOLIC PANEL TOTAL CA |
5,659
|
5,675
|
|
A9500
|
TC99M SESTAMIBI |
5,231
|
5,290
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
5,209
|
8,604
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
4,952
|
16,989
|
|
84100
|
ASSAY OF PHOSPHORUS |
4,740
|
4,749
|
|
82330
|
ASSAY OF CALCIUM |
4,619
|
4,679
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
4,532
|
21,385
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E21.0 related to the following DRG Codes:
643-645
|
